X0508 4 2026-02-23 0001636651 Ovid Therapeutics Inc. OVID 0001311404 Rona Jeffrey A C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE NEW YORK NY 10001 false true false false CBFO 0 Common Stock 2026-02-23 4 S 0 8541 1.45 D 88188 D Common Stock 2026-02-26 4 A 0 68125 0 A 156313 D Employee Stock Option (Right to Buy) 1.65 2026-02-26 4 A 0 408750 0 A 2036-02-25 Common Stock 408750 408750 D Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.45 to $1.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 28,756 shares acquired under the Issuer's employee stock purchase plan. Represents a restricted stock unit ("RSU") award. The RSUs will vest in three equal annual installments commencing on February 20, 2027, subject to the Reporting Person's continuous service through each such vesting date. Each RSU represents a contingent right to receive one share of Common Stock. The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2026, subject to the Reporting Person's continued services through each such date. /s/ Jeffrey Rona 2026-03-02